Advertisement
Journal Home
Search for
Advanced Search - MEDLINE - My Recent Searches - My Saved Searches - Search Tips
More periodicals:

81 Periodical Search Results

You searched for "predictive factor" within European Journal of Cancer

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

  Viewing 1-20  of 81 results   Next 20>

Results Page:  [1]  2  3  4  5

display abstract citation download email a colleague
Display:

  1. Impact of molecular markers on treatment selection in advanced colorectal cancer
    Hans Prenen, Sabine Tejpar, Eric Van Cutsem
    European Journal of Cancer
    September 2009 (Vol. 45Supplement 1, Pages 70-78)
    Full Text | Full-Text PDF (174 KB)

  1. Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: An exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) Corrected Proof, 23 October 2009
    Stefan Sleijfer, Monia Ouali, Martine van Glabbeke, Anders Krarup-Hansen, Sjoerd Rodenhuis, Axel Le Cesne, Pancras C.W. Hogendoorn, Jaap Verweij, Jean-Yves Blay
    European Journal of Cancer
    DOI: 10.1016/j.ejca.2009.09.022
    Abstract | Full Text | Full-Text PDF (379 KB) | Add-Ons

  1. Do we need prognostic factors in nodal-negative breast cancer? Arbiter:
    D.F Hayes
    European Journal of Cancer
    February 2000 (Vol. 36, Issue 3, Pages 302-306)
    Full Text | Full-Text PDF (129 KB)

  1. Assessment of HER2 status in breast cancer: why, when and how?
    M Dowsett, T Cooke, I Ellis, W.J Gullick, B Gusterson, E Mallon, R Walker
    European Journal of Cancer
    January 2000 (Vol. 36, Issue 2, Pages 170-176)
    Abstract | Full Text | Full-Text PDF (107 KB)

  1. Prognostic versus predictive value of biomarkers in oncology , 07 April 2008
    C.N.A.M. Oldenhuis, S.F. Oosting, J.A. Gietema, E.G.E. de Vries
    European Journal of Cancer
    May 2008 (Vol. 44, Issue 7, Pages 946-953)
    Abstract | Full Text | Full-Text PDF (564 KB)

  1. Predictive factors for node involvement in papillary thyroid carcinoma. Univariate and multivariate analyses
    E Mirallié, C Sagan, A Hamy, J Paineau, X Kahn, J.C Le Néel, J.L Auget, A Murat, M Joubert, M.F Le Bodic, J Visset
    European Journal of Cancer
    March 1999 (Vol. 35, Issue 3, Pages 420-423)
    Abstract | Full Text | Full-Text PDF (59 KB)

  1. Targeted therapies in the treatment of advanced/metastatic NSCLC , 14 July 2009
    A.G. Pallis, L. Serfass, R. Dziadziuszko, J.P. van Meerbeeck, D. Fennell, D. Lacombe, J. Welch, C. Gridelli
    European Journal of Cancer
    September 2009 (Vol. 45, Issue 14, Pages 2473-2487)
    Abstract | Full Text | Full-Text PDF (236 KB)

  1. Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancer
    M. Robain, J.Y. Pierga, M. Jouve, B. Asselain, V. Diéras, P. Beuzeboc, T. Palangié, T. Dorval, J.-M. Extra, S. Scholl, P. Pouillart
    European Journal of Cancer
    December 2000 (Vol. 36, Issue 18, Pages 2301-2312)
    Abstract | Full Text | Full-Text PDF (134 KB)

  1. C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancer
    J Sjöström, J Collan, K von Boguslawski, K Franssila, N.-O Bengtsson, I Mjaaland, P Malmström, B Østenstad, E Wist, V Valvere, J Bergh, D Skiöld-Petterson, E Saksela, C Blomqvist
    European Journal of Cancer
    March 2002 (Vol. 38, Issue 4, Pages 535-542)
    Abstract | Full Text | Full-Text PDF (130 KB)

  1. HER2: a ‘predictive factor’ ready to use in the daily management of breast cancer patients?
    M.J. Piccart, A. Di Leo, A. Hamilton
    European Journal of Cancer
    September 2000 (Vol. 36, Issue 14, Pages 1755-1761)
    Abstract | Full Text | Full-Text PDF (180 KB)

  1. Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis , 08 May 2009
    Gaëtan Des Guetz, Olivier Schischmanoff, Patrick Nicolas, Gérard-Yves Perret, Jean-François Morere, Bernard Uzzan
    European Journal of Cancer
    July 2009 (Vol. 45, Issue 10, Pages 1890-1896)
    Abstract | Full Text | Full-Text PDF (240 KB)

  1. What clinicians need to know about antioestrogen resistance in breast cancer therapy
    Amalia Milano, Lissandra Dal Lago, Christos Sotiriou, Martine Piccart, Fatima Cardoso
    European Journal of Cancer
    November 2006 (Vol. 42, Issue 16, Pages 2692-2705)
    Abstract | Full Text | Full-Text PDF (385 KB)

  1. A mutant TP53 gene status is associated with a poor prognosis and anthracycline-resistance in breast cancer patients
    E Rahko, G Blanco, Y Soini, R Bloigu, A Jukkola
    European Journal of Cancer
    March 2003 (Vol. 39, Issue 4, Pages 447-453)
    Abstract | Full Text | Full-Text PDF (138 KB)

  1. A review on the use of molecular markers of cytotoxic therapy for colorectal cancer, what have we learned? , 27 May 2009
    Miriam Koopman, Sabine Venderbosch, Iris D. Nagtegaal, Johan H. van Krieken, Cornelis J. Punt
    European Journal of Cancer
    July 2009 (Vol. 45, Issue 11, Pages 1935-1949)
    Abstract | Full Text | Full-Text PDF (1113 KB)

  1. A prospective study on predictive factors linked to the presence of BRCA1 and BRCA2 mutations in breast cancer patients
    Carla C. Wárlám-Rodenhuis, Veronica C.M. Koot, Rob B. van der Luijt, Hans F.A. Vasen, Margreet G.E.M. Ausems
    European Journal of Cancer
    July 2005 (Vol. 41, Issue 10, Pages 1409-1415)
    Abstract | Full Text | Full-Text PDF (119 KB)

  1. Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase III randomised CAIRO study , 20 May 2009
    Miriam Koopman, Sabine Venderbosch, Harm van Tinteren, Marjolijn J. Ligtenberg, Iris Nagtegaal, Johan H. Van Krieken, Cornelis J. Punt
    European Journal of Cancer
    July 2009 (Vol. 45, Issue 11, Pages 1999-2006)
    Abstract | Full Text | Full-Text PDF (501 KB)

  1. Predictive value of tumour cell proliferation in locally advanced breast cancer treated with neoadjuvant chemotherapy
    T. Aas, S. Geisler, G.E. Eide, D.F. Haugen, J.E. Varhaug, A.M. Bassøe, T. Thorsen, H. Berntsen, A.-L. Børresen-Dale, L.A. Akslen, P.E. Lønning
    European Journal of Cancer
    March 2003 (Vol. 39, Issue 4, Pages 438-446)
    Abstract | Full Text | Full-Text PDF (189 KB)

  1. Tumour response to preoperative anthracycline-based chemotherapy in operable breast cancer: the predictive role of p53 expression
    J. Sven D. Mieog, Jos A. van der Hage, Marc J. van de Vijver, Cornelis J.H. van de Velde, Cooperating Investigators of the EORTC
    European Journal of Cancer
    July 2006 (Vol. 42, Issue 10, Pages 1369-1379)
    Abstract | Full Text | Full-Text PDF (258 KB)

  1. Overexpression of c-erbB-2 is related to a higher expression of vascular endothelial growth factor (VEGF) and constitutes an independent prognostic factor in primary node-positive breast cancer after adjuvant systemic treatment
    B. Linderholm, J. Andersson, B. Lindh, L. Beckman, M. Erlanson, K. Edin, B. Tavelin, K. Grankvist, R. Henriksson
    European Journal of Cancer
    January 2004 (Vol. 40, Issue 1, Pages 33-42)
    Abstract | Full Text | Full-Text PDF (249 KB)

  1. Clinical relevance of the triple-negative breast cancer concept: Genetic basis and clinical utility of the concept
    Sabine C. Linn, Laura J. Van 't Veer
    European Journal of Cancer
    September 2009 (Vol. 45Supplement 1, Pages 11-26)
    Abstract | Full Text | Full-Text PDF (941 KB)
display abstract citation download email a colleague
Display:

  Viewing 1-20  of 81 results   Next 20>

Results Page:  [1]  2  3  4  5

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

Advertisement

Copyright © 2009 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us |
The content on this site is intended for health professionals.